GUANGZHOU, China, Oct. 14, 2025 /PRNewswire/ — News report from GDToday.

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2795657/video.mp4’, image: ‘https://mma.prnasia.com/media2/2795657/video.mp4?p=medium’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

On October 10, 2025, South China’s Guangdong province brought its vibrant animation and trendy toy culture to Tokyo with the "New Dimensions of Guangdong Animation and Trendy Toys Exhibition" at Belle Salle Akihabara, a hub for Japanese pop culture. The event, celebrating the 2025 China-Japan-ROK Year of Cultural Exchange, attracted over 10,000 visitors, including creative industry professionals, students, and fans from both countries.

Guangdong has a long legacy in animation. Masters such as Te Wei, Zhan Tong, Dai Tielang, and Ma Kexuan helped make Chinese ink-wash animation famous worldwide and inspired Japanese legends like Hayao Miyazaki and Osamu Tezuka. In 1981, Te Wei’s "Chinese Ink-Wash Animation Exhibition" in Kyoto, Japan, caused a sensation. Four decades later, Guangdong’s creators returned to Japan, presenting modern animation and trendy toys that carry the spirit of traditional ink-wash art while celebrating the long-standing collaboration between China and Japan.

From Guangdong to Tokyo, animation and trendy toys are more than just entertainment; they serve as a cultural bridge.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

TUTTOFOOD 2026 CONNECTS GLOBAL AGRI-FOOD SUPPLIERS WITH JAPAN

The Southern Europe’s leading food business platform will connect Italian and international…

Tencent Games Returns to Gamescom 2024 with its Latest Gaming Solutions and Technologies

Tencent Games to showcase innovative game development offerings to power enhanced, high…

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

Heart failure is a global pandemic with an estimated 64.3 million cases…